Astellas Pharma is headquartered in Tokyo, Japan.
Astellas Pharma disclosed revenue of 1,912,323M JPY for 2025 and 1,603,672M JPY for 2024.
Astellas Pharma has 13,643 employees.
Astellas Pharma is a life science company.
Astellas Pharma was founded in 1923.
2-5-1, Nihonbashi-Honcho Chuo-Ku,
Tokyo,
103-8411
Japan,
+81 3 3244 3000
www.astellas.com
Astellas Pharma is a pharmaceutical company committed to the therapeutic fields of urology, immunology, oncology, neuroscience, and DM complications and metabolic diseases. Astellas Pharma was founded in 1923 and is based in Tokyo, Japan.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | 13 | - | - | 2 | - | - | 15 |
| vol | $9.3B | $5.9B | $15.2B | |||||
| Sell (0.0/yr) | # | 2 | - | - | - | - | - | 2 |
| vol | $761M | $761M | ||||||
| 17 | ||||||||
| Financial | Deals |
|---|---|
|
J.P. Morgan Securities |
2 |
|
Mitsubishi UFJ Morgan Stanley |
1 |
| Legal | Deals |
|---|---|
|
Jones Day |
2 |
|
Morrison & Foerster |
1 |
|
Covington & Burling |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
